Related Experiment Video

Updated: Jul 5, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Sudden cardiac death and the role of medical therapy

Aysha Arshad1, Anisha Mandava, Ganesh Kamath

  • 1Division of Cardiology, St. Luke's-Roosevelt Hospital Center, New York, NY 10025, USA.

Progress in Cardiovascular Diseases
|May 14, 2008
PubMed

Insights

Sudden cardiac death (SCD) is a major concern, with over 300,000 US deaths annually. Current treatments focus on managing underlying conditions and preventing lethal arrhythmias, with evolving research on omega-3 fatty acids.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Pharmacology

Background:

  • Sudden cardiac death (SCD) causes over 300,000 deaths yearly in the US.
  • High-risk patients include those with coronary artery disease, post-myocardial infarction, structural heart disease, and congestive heart failure.
  • Therapeutic goals involve managing disease states and preventing lethal arrhythmias.

Purpose of the Study:

  • To review current medical therapies for high-risk patients.
  • To evaluate the efficacy and safety of anti-arrhythmic drugs.
  • To discuss the evolving role of omega-3 fatty acids in preventing SCD.

Main Methods:

  • Review of existing medical literature.
  • Analysis of treatment strategies for high-risk cardiac patients.
  • Evaluation of drug efficacy and adverse effects.

Main Results:

  • Angiotensin receptor inhibitors, beta blockers, and statins improve survival in high-risk groups.
  • Anti-arrhythmic drugs show limited efficacy and potential adverse effects.
  • The role of omega-3 fatty acids in SCD prevention is under ongoing investigation.

Conclusions:

  • Medical therapy for high-risk patients should focus on disease management and arrhythmia prevention.
  • Established medications like ACE inhibitors, beta-blockers, and statins are beneficial.
  • Further research is needed to clarify the role of omega-3 fatty acids in reducing sudden cardiac death.

More Related Videos

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease12:15

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Published on: February 8, 2022

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...